Funding
This study was mainly supported by Fundação de Apoio ao Ensino Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FAEPA), Brasil, and received partial support from the CVE - Centro de Vigilância Epidemiológica “Prof. Alexandre Vranjac” da Secretaria da Saúde do Estado de São Paulo (SES-SP). The funding sources didn’t have any role in the writing, the decision to submit the manuscript for publication or any other aspect pertinent to study conduction. There was no funding from pharmaceutical companies or other agencies. All study data were analysed by the corresponding author, as well as the final responsibility for the decision to submit for publication.